Journal Information
Vol. 45. Issue 5.
Pages 271-279 (June - July 2021)
Vol. 45. Issue 5.
Pages 271-279 (June - July 2021)
Full text access
Fate of rejected manuscripts in the journal Medicina Intensiva during 2015–2017 period
Destino de los artículos rechazados en Medicina Intensiva en el período 2015–2017
J.L. García-Garmendiaa,
Corresponding author

Corresponding author.
, F. Gordo-Vidalb, S.R. Leal-Novalc, R. Amaya-Villarc, N. Raimondid, A. Ochagavía-Calvoe, J. Garnacho-Monterof
a Hospital San Juan de Dios del Aljarafe, Sevilla, Spain
b Hospital Universitario del Henares, Grupo de investigación en Patología Crítica, Universidad Francisco de Vitoria, Madrid, Spain
c Universitario Virgen del Rocío, Sevilla, Spain
d Hospital Municipal Juan A. Fernández, Buenos Aires, Argentina
e Corporación Sanitaria Parc Taulí, Barcelona, Spain
f Hospital Universitario Virgen Macarena, Sevilla, Spain
This item has received
Article information
Full Text
Download PDF
Figures (1)
Tables (4)
Table 1. Main journals of publication of the articles rejected by Medicina Intensiva.
Table 2. Univariate analysis of variables associated to publication after rejection by Medicina Intensiva according to different factors.
Table 3. Multivariate analysis of variables associated to publication in journals indexed in PubMed after rejection by Medicina Intensiva.
Table 4. Studies on the publication of rejected articles, with rejection rate, publication rate and mean time to publication.
Show moreShow less

To know the fate of the rejected manuscripts in Medicina Intensiva journal (MI) from 2015 to 2017 with surveillance until 2019.


Retrospective observational study.


Biomedical journals publication.


Rejected manuscripts in MI journal.



Main variables of interest

Time of publication, impact factor (IF), generated citations and variables associated to publication.


The 69% (420) of analyzed articles (344 originals and 263 scientific letters) were rejected, and 205 (48.8%) were subsequently published, with 180 citations of 66 articles. Journal IF was lower in 173 (84.4%) articles. The number of FI-valid citations was higher than the FI of MI in 21 articles. Origin of manuscript OR 2,11 (IC 95% 1.29–3.46), female author OR 1.58 (IC 95% 1.03–2.44), english language OR 2,38 (IC 95% 1.41–4.0) and reviewed papers OR 1.71 (IC 95% 1.10–2.66) were associated to publication in PubMed database.


The rejected articles in MI have a mean publication rate in other journals. Most of these articles are published in journals with less IF and fewer citations than the IF of MI.

Rejected articles
Publication rate
Impact factor
Peer review

Conocer el destino de los trabajos rechazados en Medicina Intensiva (MI) en el período del 2015 al 2017 con seguimiento hasta el 2019.


Estudio retrospectivo observacional.


Publicaciones en revistas biomédicas.


Manuscritos rechazados en la revista Medicina Intensiva.



Variables de interés

Tiempo de publicación, factor de impacto (FI), citas generadas y variables asociadas con a la publicación.


De 344 originales y 263 cartas científicas, se rechazaron 420 (69,2%). Se publicaron después 205 (48,8%) y 66 de ellos generaron 180 citas. El FI de las revistas fue menor en 173 casos (84,4%). En 21, el número de citas válidas para FI fue mayor que el FI de MI. El origen del manuscrito odds ratio (OR) 2,11 (IC 95% 1,29 a 3,46), la mujer como autora OR 1,58 (IC 95% 1,03 a 2,44), que estuviera en lengua inglesa OR 2,38 (IC 95% 1,41 a 4,0) y que el artículo hubiera pasado a revisores OR 1,71 (IC 95% 1,10 a 2,66) se asociaron con mayor tasa de publicación en revistas indexadas en PubMed.


Los artículos rechazados en MI tienen una tasa media de publicación en otras revistas, principalmente con menos FI y generando menor número de citas que el FI de MI.

Palabras clave:
Artículos rechazados
Tasa de publicación
Factor de impacto
Revisión por pares
Full Text

Peer review is the standard used by scientific journals to select articles for publication. However, there is no procedure to ensure that certain papers of sufficient quality are not rejected, or that some studies with methodological deficiencies are not accepted.1

High impact factor (IF) journals reject many of the originals they receive. This is due both to the quality demands of the editorial committees and to the need to present a limited number of papers in order to keep the IF high, since this is associated to the prestige of the journal.2

This rejection rate in turn gives rise to a wave of submissions to other journals, usually of lower IF, which again review the article using the same system. This phenomenon has been evaluated in many previous studies.3–20 In this evaluation circuit, the original text may gain quality thanks to the recommendations of the editorial teams and reviewers,17 or alternatively the text may become obsolete upon being rejected on several occasions. A high publication rate following a rejection may indicate either low quality of the review process or the need to limit the publications in the original journal in order to maintain its IF.3 A low publication rate after rejection may reflect the poor quality of the submitted originals, indicating limited interest on the part of the original journal.

Another issue is referred to the IF of the journals that posteriorly publish the rejected originals. It is to be expected that authors who see their paper being rejected will seek to publish it in journals with a lower IF.3,4,6–9,11–13,15,17 This is not always the case, however, and the IF of the alternative journal may actually be higher than that of the original journal, thus indicating inadequate assessment of the quality of the document by the latter.

The citations that arise from secondary publications are also indicators of the quality of the editorial process, though they often appear in journals belonging to other categories.20 The non-detection of articles that generate many citations could affect the IF of a journal as a loss of opportunity, and should be regarded by the editorial team as a sentinel event of the process if publication is made in a journal of the same category.

The aim of the present study was to analyze the publication in other journals and the generation of citations of articles rejected by the editorial board of Medicina Intensiva (MI), investigating the variables associated to such publication.

Material and methods

A retrospective study was made of the originals and scientific letters rejected by the editorial board of MI in the period 2015–2017, and which were published in other scientific journals between 2015–2019. The year 2015 was selected as the starting point, coinciding with the change in editorial team.

Use was made of a database of rejected articles provided by the Publisher Elsevier containing all the documents rejected in the mentioned period and which included the title, authors, submitting person, key words, abstract, submission date and rejection notification date.

The PubMed and Google Scholar databases were used to check publication after the rejection, employing the name of the first author and of the submitting person if different from the first author, the title of the paper or a combination of author and article key words. In order to consider the article to correspond to the same text as the rejected article, it was required to include the same first authors and a similar title and abstract, and had to be published after the date of rejection. Publications in university repositories or local bulletins were not considered. In cases of doubt, consensus was reached among three investigators (JGM, FGV, JLGG). The IF of the journal was analyzed in the Journal of Citations Report (JCR) corresponding to the year in which the article was published, calculating the difference with respect to the IF of MI that year. The IF was considered to be similar if the difference was ± 0.3 points (considering 20% of the mean of the IF of the three years), higher if >0.3 points, and lower if <0.3 points.

The number of citations generated by the articles published after rejection was analyzed using the Scopus database and Google Scholar. Mentions arising from articles that were duplicates since they appeared in two languages were not regarded as citations.

The following were analyzed as variables possibly related to publication: the gender of the submitting person, the gender of the first author, coincidence of the submitting person and the first author, the country of origin of the manuscript, the language in which the paper was submitted, the type of manuscript (original/scientific letter), evaluation by reviewers and the processing time (in days).

Following publication, we analyzed the publication time calculated as the difference between publication and the notification of rejection; whether the journal appeared in PubMed; whether the journal had an IF in JCR; and whether it corresponded to the specialty of intensive care. We also examined whether it was contained in the Critical Care Medicine category in JCR, which is the only one in which MI appears; the IF in the year of publication; the number of citations generated; and the amount valid for calculating the IF.

Statistical analysis

A descriptive study was made, calculating the mean and median and standard deviation (SD) with the interquartile range (IQR) for continuous variables, and percentages for qualitative variables. Qualitative variables were compared with the Chi-square test or Fisher exact test, while analysis of variance (ANOVA) or the Kruskal–Wallis test was used in the case of quantitative variables. In the multivariate analysis we used forward stepwise logistic regression analysis, based on the likelihood ratio, entering those variables which in the univariate analysis yielded p<0.10. The Hosmer–Lemeshow test was used to assess calibration, with calculation of the odds ratio (OR) and corresponding 95% confidence interval (95%CI). Statistical significance was considered for p<0.05 in all cases.


In the period 2015–2017, a total of 360 originals and 278 scientific letters were received for evaluation by the editorial board of MI. Based on the signing authors, a total of 16 originals and 15 letters were removed, thus leaving 344 originals and 263 scientific letters for analysis (Fig. 1). The overall rejection rate was 69.2%, distributed over the three years as follows: 69.1% (2015), 67.4% (2016) and 70.8% (2017) (p=0.69).

Figure 1.

Flowchart of articles rejected by Medicina Intensiva and subsequently published elsewhere.


Of the 420 rejected articles, there were more originals (n=241; 57%) than scientific letters (n=179; 43%). The proportion of originals rejected was 70.1%, versus 68.1% in the case of the scientific letters (p=nonsignificant [NS]). A total of 262 documents, of which 98 were originals (37%) and 164 scientific letters (63%), were rejected without being evaluated by the reviewers, with a mean processing time of 9.3 days (SD 6.2). A total of 258 rejected texts were submitted by males (61.4%), though the first author was a male in 57.4% of the cases. The first author and the submitting person were the same individual in 325 cases (77.4%). No submitting person gender difference was observed between the accepted or rejected articles (60.2% versus 61.4%; p=0.75).

Of the 420 rejected articles, 205 (48.8%) were subsequently published in other journals (122 originals and 83 scientific letters). The percentage of texts published after rejection did not vary significantly between the different years analyzed: 2015 (44.7%), 2016 (53.1%) and 2017 (48.8%) (p=0.53). Table 1 shows the main journals in which the rejected articles appeared.

Table 1.

Main journals of publication of the articles rejected by Medicina Intensiva.

Medicina Clínica (Barc) 
Revista Española de Anestesiología y Reanimación 
Anales de Pediatría (Barc) 
Revista Brasileira Terapia Intensiva 
Revista Española de Quimioterapia 
Revista de Neurología 
Acta Colombiana de Cuidado Intensivo 
Archivo Argentina de Pediatría 
Cirugía Españolaa 
Enfermería Intensiva 
Indian Journal of Critical Care Medicine 
Neurología Argentina 
Revista Argentina de Anestesiología 
Revista Colombiana de Anestesiología 
Revista Colombiana de Cardiología 
Others with ≤2  133 

Journals with higher impact factor (IF) than Medicina Intensiva in the Journal of Citation Report in that year.

Of the 205 documents published after rejection, 132 (64.4%) appeared in journals indexed by PubMed, 83 (40.5%) in 48 journals with IF in JCR, and 41 (20%) in 26 critical care journals – though only three appeared in two publications of the same category in JCR (Intensive Care Medicine and MI itself).

Most of the articles were published in the year following rejection: 2015 (54%), 2016 (57%) and 2017 (64%). The median (IQR) time to publication after rejection was 410 (360) days in 2015, 366 (285) days in 2016, and 305 (267) days in 2017 (p=0.177). The median (IQR) processing time in MI of the published documents was 22 (11) days in the overall period.

A total of 83 (40.5%) articles were published in journals with IF in JCR. The IF of these journals was higher in 17 (8.3%), similar in 15 (7.3%) and lower in 173 (84.4%) texts, with 122 (59.5%) being published in journals without IF. Two of the articles were subsequently published in MI, following the introduction of substantial changes.

A total of 66 articles (15.7% of the rejected papers) were cited on up to 180 occasions from other journals. Among these articles there were 51 originals and 15 scientific letters. Of the total of 180 citations, 104 (57.8%) were valid for calculation of the IF. The mean number of citations generated was 0.80 per published document and 2.7 per cited article, with 2.31 valid for IF; the maximum was 11 for one study that generated 8 citations valid for the calculation of IF. We detected 21 articles (10.2% of those published, 5% of those rejected) that provided a number of citations valid for an IF higher than that of MI in that year.

Table 2 shows the univariate analyses of the variables associated to publication after rejection, according to different factors. No significant differences in the studied variables were recorded for publication in any journal, except as regards non-coincidence of the submitting person and first author. In the case of publication in journals indexed in PubMed, differences were observed if the first author was a female, if the article came from Europe or North America, if it was written in English, and if it was evaluated by the reviewers. There were also variations in the publication rate if the first author and the submitting person were not the same. On analyzing the differences according to publication in a journal of the specialty, a lesser origin from Spain, Europe or North America was observed, with more texts written in English, and more originals versus scientific letters. On analyzing the variables related to publication in journals with IF, only an origin in Europe or North America was associated to a higher publication rate.

Table 2.

Univariate analysis of variables associated to publication after rejection by Medicina Intensiva according to different factors.

  Published  Not published  OR (95%CI) 
  n=205  n=215     
Female gender submitting person, n (%)  82 (40.0%)  80 (37.2%)  1.13 (0.76–1.67)  0.557 
Female gender first author, n (%)  90 (43.9%)  89 (41.4%)  1.11 (0.75–1.63)  0.604 
First author and submitting person coincide, n (%)  150 (73.2%)  175 (81.4%)  0.62 (0.39−0.99)  0.044 
Origin Spain, n (%)  116 (56.7%)  130 (60.5%)  0.86 (0.58–1.27)  0.420 
Origin Europe or North America, n (%)  131 (63.9%)  136 (63.3%)  1.03 (0.69–1.53)  0.891 
English language, n (%)  53 (25.8%)  40 (18.6%)  1.53 (0.96–2.43)  0.074 
Original versus scientific letter, n (%)  122 (59.5%)  119 (55.3%)  1.19 (0.80–1.75)  0.388 
Evaluated by reviewers, n (%)  82 (40.0%)  76 (35.3%)  1.22 (0.82–1.81)  0.325 
  Published in PubMed  Not published in PubMed  OR (95%CI) 
  n=132  n=288     
Female gender submitting person, n (%)  57 (43.2%)  105 (36.5%)  1.32 (0.87–2.01)  0.189 
Female gender first author, n (%)  67 (50.8%)  112 (38.9%)  1.62 (1.07–2.45)  0.022 
First author and submitting person coincide, n (%)  92 (69.7%)  233 (80.9%)  0.54 (0.34–0.87)  0.011 
Origin Spain, n (%)  83 (62.9%)  163 (56.6%)  1.30 (0.85–1.98)  0.225 
Origin Europe or North America, n (%)  94 (71.2%)  173 (60.1%)  1.64 (1.05–2.57)  0.028 
English language, n (%)  41 (31.1%)  52 (18.1%)  2.04 (1.27–3.29)  0.003 
Original versus scientific letter, n (%)  79 (59.8%)  162 (56.2%)  1.16 (0.76–1.76)  0.489 
Evaluated by reviewers, n (%)  61 (46.2%)  97 (33.7%)  1.69 (1.11–2.58)  0.014 
  Published in intensive care journal  Not published in intensive care journal  OR (95%CI) 
  n=41  n=379     
Female gender submitting person, n (%)  16 (39.0%)  146 (38.5%)  1.02 (0.53–1.98)  0.950 
Female gender first author, n (%)  16 (39.0%)  163 (43.0%)  0.85 (0.44–1.64)  0.624 
First author and submitting person coincide, n (%)  30 (73.2%)  295 (77.8%)  0.78 (0.37–1.62)  0.498 
Origin Spain, n (%)  14 (34.1%)  232 (61.2%)  0.33 (0.17−0.65)  0.001 
Origin Europe or North America, n (%)  19 (46.3%)  248 (65.4%)  0.46 (0.24−0.87)  0.016 
English language, n (%)  15 (36.6%)  78 (20.6%)  2.23 (1.13–4.41)  0.019 
Original versus scientific letter, n (%)  32 (78.0%)  209 (55.1%)  2.89 (1.34–6.22)  0.005 
Evaluated by reviewers, n (%)  18 (43.9%)  140 (36.9%)  1.34 (0.70–2.56)  0.382 
  Published in journal with IF  Not published in journal with IF  OR (95%CI) 
  n=83  n=337     
Female gender submitting person, n (%)  34 (41.0%)  128 (38.0%)  1.13 (0.69–1.85)  0.617 
Female gender first author, n (%)  40 (48.2%)  139 (41.2%)  1.33 (0.82–2.15)  0.252 
First author and submitting person coincide, n (%)  60 (72.3%)  265 (78.6%)  0.71 (0.41–1.22)  0.216 
Origin Spain, n (%)  56 (67.5%)  190 (56.4%)  1.61 (0.97–2.67)  0.066 
Origin Europe or North America, n (%)  62 (74.7%)  205 (60.8%)  1.90 (1.11–3.27)  0.019 
English language, n (%)  23 (27.7%)  70 (20.8%)  1.46 (0.85–2.53)  0.173 
Original versus scientific letter, n (%)  46 (55.4%)  195 (57.9%)  0.91 (0.56–1.47)  0.687 
Evaluated by reviewers, n (%)  37 (44.6%)  121 (35.9%)  1.44 (0.88–2.34)  0.144 

IF: impact factor; CI: confidence interval; OR: odds ratio.

Multivariate analyses were made of the variables independently associated to publication after rejection in a journal indexed in PubMed (Table 3). These were found to be a female first author OR 1.58 (95%CI 1.03–2.44; p=0.037), an origin in Europe or North America OR 2.11 (95%CI 1.29–3.46; p=0.003), papers written in English OR 2.38 (95%CI 1.41–4.04; p=0.001), and papers evaluated by the reviewers OR 1.71 (95%CI 1.10–2.66; p=0.017). The only variable found to be related to publication in a journal of the specialty was an origin from a country other than Spain OR 3.04 (95%CI 1.55–6.00; p=0.001). The variables associated to publication in journals with IF were an origin in Europe or North America OR 2.27 (95%CI 1.28–4.03; p=0.005), and papers written in English OR 1.91 (95%CI 1.06–3.42; p=0.031).

Table 3.

Multivariate analysis of variables associated to publication in journals indexed in PubMed after rejection by Medicina Intensiva.

  OR (95%CI) 
English language  2.38 (1.41–4.04)  0.001 
Origin Europe or North America  2.11 (1.29–3.46)  0.003 
Evaluated by reviewers  1.71 (1.10–2.66)  0.017 
First author female  1.58 (1.03–2.44)  0.037 

CI: confidence interval; OR: odds ratio.


The present study shows that the publication rate following editorial rejection by MI is comparable to that of other journals, and that such publication mainly takes place in journals with a lower IF or belonging to categories different from intensive care. Furthermore, the publication rate varies according to the geographical origin of the article, the language in which it is written, and the gender of the author, as well as evaluation by the reviewers.

The overall rejection rate of manuscripts submitted to medical journals varies greatly between 17–89%.3,6,9,10,12,17–19,21–27 Within this range, the rejection rate of MI is consistent with the average for other journals, and has not experienced significant changes in the three years of the study period. The causes underlying the variability of these rates are varied, and in most cases are adjusted by the journals themselves, with a view to maintaining a balance among publication demand, quality, publication delay and maintenance or improvement of the IF.2,3

The internal management of the editorial boards of medical journals has been studied in relation to the acceptance or rejection of the articles received. The lack of concordance among reviewers,23 rejection as first assessment,28 the nature of the article as an original paper,24 a large number of reviewers,23,29 or reviewer suggestion by the submitting authors23 have been associated to a higher rejection rate.

The statistical analysis made, or the interpretation of the results, is a very relevant cause of rejection.2,30 Some of the issues in this regard are: incomplete introduction,31 inappropriate research question,31–33 poorly defined target population,33 poorly defined variables,33 inadequate methodology,21,33–36 inappropriate statistical analysis,21,34 poor management of covariables,21 problems with the control group,21 lack of data quality,31–34 poorly structured results,33,35 poor interpretation of results33–35 and deficient conclusions.21,31,33 In some cases the editorial boards focus on the improvement of methodological quality as a means to raise the IF of the journal.2,33,37 Other issues associated to rejection are a lack of message,34 a lack of originality,34,36 irrelevance for the journal in question,31,34,35 incorrect style,31,32,34,35 and non-scientific31,35 or inadequate conduct.32

The proportion of articles that are rejected and which subsequently appear published in other journals has been analyzed by different authors.3–20 This proportion varies greatly from 18 to 77%. The publication rate of the articles rejected by MI is in the average range (48.8%). Table 4 compares the main studies on publication after rejection, where this variability can be seen. This situation may be explained in part by different follow-up periods, the analysis of different types of articles, and because a high IF attracts more studies and of higher quality. No linear correlation has been found between the rejection rate and the publication rate.

Table 4.

Studies on the publication of rejected articles, with rejection rate, publication rate and mean time to publication.

  Years of study  Journal  Overall rejection rate (%)  Publication rate (%)  Publications in journals with lower IF (%)  Mean time to publication (months) 
Chew 1991  1986  Am J Roentgenol    64%    14.7 
Ray 2000  1993–94  Am J Med  89%  69%    18.4 
Hall 2007  2002  Epidemiology  70%  77%     
McDonald 2007  2004  Am J Neuroradiol    56.8%    15.8 
Silberzweig 2008  2004  J Vasc Interv Radiol    58%    15.5 
Armstrong 2008  2004−05  J Am Acad Dermatol  50%  41%  80%   
Wijnhoven 2009  2006  Br J Surg    65.8%  97.7%  13.8 
Dewan 2010  2002  Indian Pediatr  67%  18%  74%  17.5 
Okike 2012  2004−05  J Bone Joint Surg Am    75.8%  72.7%  21.6 
Zoccali 2015  2012  Nephrol Dial Transplant  86%  60%  94%   
Grant 2015  2010−11  Acad Emerg Med  68%  66%  94%  16.7 
Hollyday 2015  2010 and 12  Int J Radiat Oncol Biol Phys  65.6%  71.7%     
Casnici 2017  1997−2011  Scientometrics    19.3%  43%   
Cejas 2017  2014  Am J Roentgenol    59%     
Docherty 2017  2013  Anaesthesia  87.2%  54.7%  97%   
Earnshaw 2017  2011−13  Clin Otolaryngol    55.7%  82%  15.1 
Citerio 2018  2013−16  Intensive Care Med  89%  39.6%  74.8%  11 
Chung, 2020  2015−19  Kidney Res Clin Pract  65%  69%     
Karlıdağ, 2020  2015−16  Turk Arch Otorhinolaryngol  56.6%  75.5%   
García-Garmendia 2021  2015−17  Med Intensiva  64%  48.8%  84.4%  13.1 

IF: impact factor.

The analysis of the variables associated to the publication of articles that have been rejected has evidenced a relationship with evaluation by reviewers,12 a variable link to certain geographical origins11,34 and an association to the fact that those authors that modify the content according to the recommendations of the reviewers are published in journals with a higher IF.17 In our study we identified no variables of interest related to publication in any journal. However, on analyzing those indexed in PubMed, we found female gender of the submitting person to be associated to a greater probability of ulterior publication. Other determinant elements were the geographical origin and evaluation by the reviewers. Although the associations of gender to publication rate and article rejection have been studied before,38,39 the data indicate a lesser publication rate if the submitting person was female.11 An explanation for our findings could be that women are more constant in the quest for publication, or that women are more implicated in the successive manuscript revision processes – though we lack data corroborating this. During the analyzed period, there were no gender differences in the rates of acceptance and rejection of originals and scientific letters on the part of the editorial board of MI.

The publication rate in journals of the same category versus others of a different category has been studied elsewhere,20 though without analysis of the associated variables as in our study. The only observation has been a greater delay in publication in journals of a different category; we did not evidence this in our study, however. The only variable independently associated to publication in journals of the same category was an origin outside Spain.

The great majority of articles published after rejection appear in journals with a lower IF or no IF. In fact, the mean citations generated by the published articles is lower than the IF of the journal in the three years of the study, and even lower when only considering those citations valid for the calculation of IF. Only 5% of the rejected manuscripts generated more citations valid for the IF than the IF of MI corresponding to that same year. The mean proportion of articles published in journals with a lower IF in other studies is 81% (range 43–98%),3,4,6–9,11–13,15,17 with MI being located in the average zone (84.4%). All this validates the manuscript acceptance and rejection editorial process.

The present study has some limitations. The databases used might not have been sufficiently exhaustive in obtaining publications, though the results comparable to those of other series reinforce the data obtained. Another possible limitation is the fact that other types of manuscripts were not included, though we considered it preferable to focus on these two categories that have more possibilities of being published and cited.


The articles rejected in MI show a stable subsequent publication rate, similar to that of other journals. Most of these texts are published in journals with a lower IF and with a number of citations below the IF of MI. A European or North American origin, papers in English, a woman as submitting person, and evaluation by reviewers are variables associated to a higher rate of posterior publication in journals indexed in PubMed.

Author contributions

José Luis García Garmendia, data generation and compilation, data analysis, drafting of first manuscript. Federico Gordo Vidal, data generation and compilation, review of the text. Santiago Ramón Leal-Noval, data generation and compilation, review of the text. Rosario Amaya Villar, data generation and compilation, review of the text. Néstor Raimondi, data generation and compilation, review of the text. Ana Ochagavía Calvo, review of the text. José Garnacho Montero, original idea, data generation and compilation, and review of the text.

Financial support

This study has received no financial support.

Conflicts of interest

The authors declare that they have no conflicts of interest.


Thanks are due to Montserrat Miralles Alemany and Montserrat Valero, of the Publisher Elsevier, for their crucial collaboration in obtaining the information for this article.

L.C. Silva Ayçaguer.
Errores metodológicos frecuentes en la investigación clínica.
Med Intensiva., 42 (2018), pp. 541-546
S.R. Leal-Noval, R. Amaya-Villar, J.L. García-Garmendia, F. Gordo-Vidal, J. Garnacho-Montero.
Política editorial en Medicina Intensiva.
Med Intensiva., 41 (2017), pp. 63-66
G. Citerio, E. Deutsch, E. Sala, M. Lavillonnière, A. Perner, S. Jaber, et al.
Fate of manuscripts rejected by Intensive Care Medicine from 2013 to 2016: a follow-up analysis.
Intensive Care Med., 44 (2018), pp. 2300-2301
N. Casnici, F. Grimaldo, N. Gilbert, P. Dondio, F. Squazzoni.
Assessing peer review by gauging the fate of rejected manuscripts: the case of the Journal of Artificial Societies and Social Simulation.
Scientometrics., 113 (2017), pp. 533-546
C. Cejas.
Analysis of the revision process by American Journal of Roentgenology Reviewers and Section Editors: metrics of rejected manuscripts and their final disposition.
AJR Am J Roentgenol., 208 (2017), pp. 1181-1184
A.B. Docherty, A.A. Klein.
The fate of manuscripts rejected from Anaesthesia.
Anaesthesia., 72 (2017), pp. 427-430
C.H. Earnshaw, C. Edwin, J. Bhat, M. Krishnan, C. Mamais, S. Somashekar, et al.
An analysis of the fate of 917 manuscripts rejected from Clinical Otolaryngology.
Clin Otolaryngol., 42 (2017), pp. 709-714
C. Zoccali, D. Amodeo, A. Argiles, M. Arici, G. D’arrigo, P. Evenepoel, et al.
The fate of triaged and rejected manuscripts.
Nephrol Dial Transplant., 30 (2015), pp. 1947-1950
W.D. Grant, D.C. Cone.
If at first you don’t succeed: the fate of manuscripts rejected by Academic Emergency Medicine.
Acad Emerg Med., 22 (2015), pp. 1213-1217
E.B. Holliday, G. Yang, R. Jagsi, K.E. Hoffman, K.E. Bennett, C. Grace, et al.
Fate of manuscripts rejected from the Red Journal.
Int J Radiat Oncol Biol Phys., 91 (2015), pp. 3-10
K. Okike, M.S. Kocher, B.U. Nwachukwu, C.T. Mehlman, J.D. Heckman, M. Bhandari.
The fate of manuscripts rejected by The Journal of Bone and Joint Surgery (American Volume).
J Bone Joint Surg Am., 94 (2012),
P. Dewan, P. Gupta, D. Shah.
Fate of articles rejected by Indian Pediatrics.
Indian Pediatr., 47 (2010), pp. 1031-1035
B.P. Wijnhoven, C.H. Dejong.
Fate of manuscripts declined by the British Journal of Surgery.
Br J Surg., 97 (2010), pp. 450-454
R.J. McDonald, H.J. Cloft, D.F. Kallmes.
Fate of manuscripts rejected from the American Journal of Neuroradiology: outcomes and commentary.
AJNR Am J Neuroradiol., 28 (2007), pp. 1430-1434
R.J. McDonald, H.J. Cloft, D.F. Kallmes.
Fate of manuscripts previously rejected by the American Journal of Neuroradiology: a follow-up analysis.
AJNR Am J Neuroradiol., 30 (2009), pp. 253-256
J.E. Silberzweig, A.S. Khorsandi.
Outcomes of rejected Journal of Vascular and Interventional Radiology manuscripts.
J Vasc Interv Radiol., 19 (2008), pp. 1620-1623
A.W. Armstrong, S.Z. Idriss, A.B. Kimball, J.D. Bernhard.
Fate of manuscripts declined by the Journal of the American Academy of Dermatology.
J Am Acad Dermatol., 58 (2008), pp. 632-635
S.A. Hall, A.J. Wilcox.
The fate of epidemiologic manuscripts: a study of papers submitted to epidemiology.
Epidemiology., 18 (2007), pp. 262-265
J. Ray, M. Berkwits, F. Davidoff.
The fate of manuscripts rejected by a general medical journal.
Am J Med., 109 (2000), pp. 131-135
F.S. Chew.
Fate of manuscripts rejected for publication in the AJR.
AJR Am J Roentgenol., 156 (1991), pp. 627-632
C.M. Hesterman, C.L. Szperka, D.P. Turner.
Reasons for manuscript rejection after peer review from the Journal Headache.
Headache., 58 (2018), pp. 1511-1518
A.B. Rosenkrantz, M. Harisinghani.
Metrics for original research articles in the AJR: from first submission to final publication.
AJR Am J Roentgenol., 204 (2015), pp. 1152-1156
L.A. Sposato, B. Ovbiagele, S.C. Johnston, M. Fisher, G. Saposnik, Stroke Outcome Research Working Group (
A peek behind the curtain: peer review and editorial decision making at Stroke.
Ann Neurol., 76 (2014), pp. 151-158
F. Enquselassie.
Peer-review and editorial process of the Ethiopian Medical Journal: ten years assessment of the status of submitted manuscripts.
Ethiop Med J., 51 (2013), pp. 95-103
R.L. Kravitz, P. Franks, M.D. Feldman, M. Gerrity, C. Byrne, W.M. Tierney.
Editorial peer reviewers’ recommendations at a general medical journal: are they reliable and do editors care?.
S. Chung, J. Lee, T.-H. Yoo, G.-H. Kim.
The fate of manuscripts rejected from Kidney Research and Clinical Practice.
Kidney Res Clin Pract., 39 (2020), pp. 230-231
T. Karlıdağ, C. Bilgen, T.K. Erdağ.
Fate of manuscripts rejected by Turkish Archives of Otorhinolaryngology between 2015 and 2017.
Turk Arch Otorhinolaryngol., 58 (2020), pp. 78-79
A.M. Vintzileos, C.V. Ananth, A.O. Odibo, S.P. Chauhan, J.C. Smulian, Y. Oyelese.
The relationship between a reviewer’s recommendation and editorial decision of manuscripts submitted for publication in obstetrics.
Am J Obstet Gynecol., 211 (2014),
T. Stamm, U. Meyer, H.P. Wiesmann, J. Kleinheinz, M. Cehreli, Z.C. Cehreli.
A retrospective analysis of submissions, acceptance rate, open peer review operations, and prepublication bias of the multidisciplinary open access journal Head & Face Medicine.
Head Face Med., 3 (2007), pp. 27
J.L. García-Garmendia, F. Maroto-Monserrat.
Interpretación de resultados estadísticos.
Med Intensiva., 42 (2018), pp. 370-379
H.S. Meyer, S.J. Durning, D.P. Sklar, L.A. Maggio.
Making the first cut: an analysis of academic medicine editors’ reasons for not sending manuscripts out for external peer review.
Acad Med., 93 (2018), pp. 464-470
T. Wyness, C.N. McGhee, D.V. Patel.
Manuscript rejection in ophthalmology and visual science journals: identifying and avoiding the common pitfalls.
Clin Exp Ophthalmol., 37 (2009), pp. 864-867
J.L. García Garmendia.
Actualización en metodología en Medicina Intensiva.
Med Intensiva., 42 (2018), pp. 180-183
P. Gupta, G. Kaur, B. Sharma, D. Shah, P. Choudhury.
What is submitted and what gets accepted in Indian Pediatrics: analysis of submissions, review process, decision making, and criteria for rejection.
Indian Pediatr., 43 (2006), pp. 479-489
B. Kool, A. Ziersch, P. Robinson, L. Wolfenden, J.B. Lowe.
The «Seven deadly sins» of rejected papers.
Aust N Z J Public Health., 40 (2016), pp. 3-4
C. Turcotte, P. Drolet, M. Girard.
Study design, originality and overall consistency influence acceptance or rejection of manuscripts submitted to the Journal.
Can J Anaesth., 51 (2004), pp. 549-556
J.L. García Garmendia.
Evaluación y cierre de la serie sobre metodología en Medicina Intensiva.
Med Intensiva., 43 (2019), pp. 121-123
F. González Sala, J. Osca-Lluch.
Desigualdad de género en órganos directivos y producción científica de las revistas iberoamericanas de psicología de mayor visibilidad internacional.
Rev Esp Doc Cient., 41 (2018),
A. Alonso-Arroyo, M. Bolaños-Pizarro, G. González-Alcaide, M. Villamón, R. Aleixandre-Benavent.
Análisis de género, productividad científica y colaboración de las profesoras universitarias de Ciencias de la Salud en la Comunidad Valenciana (2003–2007).
Rev Esp Doc Cient., 33 (2010), pp. 624-642

Please cite this article as: García-Garmendia JL, Gordo-Vidal F, Leal-Noval SR, Amaya-Villar R, Raimondi N, Ochagavía-Calvo A, et al. Destino de los artículos rechazados en Medicina Intensiva en el período 2015–2017. Med Intensiva. 2021;45:271–279.

Copyright © 2021. Elsevier España, S.L.U. and SEMICYUC
Medicina Intensiva (English Edition)
Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?